Načítá se...
Colchicine intolerance in FMF patients and primary obstacles for optimal dosing
BACKGROUND/AIM: Colchicine is the mainstay of treatment in FMF. However, in daily practice it is not easy to maintain effective colchicine doses in a substantial number of patients due to its side effects. In this study, we aimed to investigate prevalence and risk factors for colchicine side effects...
Uloženo v:
| Vydáno v: | Turk J Med Sci |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Scientific and Technological Research Council of Turkey
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7491296/ https://ncbi.nlm.nih.gov/pubmed/32512676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-2001-261 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|